Category Specific RSS

chimeric therapeutics

Chimeric Therapeutics granted US patent for its blood cancer technology

The United States Patent and Trademark Office (USPTO) has recently granted a patent to Australia-based clinical-stage cell therapy company Chimeric…

1 year ago

Chimeric’s cell therapy drug moves on to Phase 1B trial to treat malignant brain cancer

In 2020, the Department of Health and Aged Care revealed that approximately 2,000 Australians were diagnosed with brain cancer. New…

2 years ago

There are no scorpions involved in this company’s latest cancer drug

Most company announcements include a one paragraph summary of the business conveniently located at the bottom of the page. Chimeric…

3 years ago